JPM vs NECB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NECB presents a classic deep-value opportunity, trading significantly below its Graham Number ($45.05) and Intrinsic Value ($49.56). While the Piotroski F-Score of 4/9 indicates only stable financial health rather than strong improvement, the company maintains a healthy ROE of 13.26% and a very conservative dividend payout ratio. The primary headwinds are bearish insider sentiment and a weak technical trend, but the fundamental valuation gap is too wide to ignore.
Compare Another Pair
Related Comparisons
JPM vs NECB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Northeast Community Bancorp, Inc. (NECB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.